(Q36177570)

12 August 2017

1 reference

title

The role of leukotrienes in allergic rhinitis (English)

1 reference

12 August 2017

1

Marc Peters-Golden

1 reference

12 August 2017

William R Henderson

2

1 reference

12 August 2017

language of work or name

1 reference

1 June 2005

1 reference

Annals of Allergy, Asthma & Immunology

12 August 2017

published in

1 reference

12 August 2017

volume

94

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

609-18; quiz 618-20, 669

1 reference

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

1 reference

7 January 2021

Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Rhinitis, sinusitis, and polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Mediators of inflammation and the inflammatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Changes in bronchial responsiveness following nasal provocation with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Inflammatory cells in asthma: mechanisms and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Cysteinyl leukotrienes in asthma: old mediators up to new tricks

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population‐based sample of children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Leukotriene antagonism reduces the generation of endothelin-1 and interferon-gamma and inhibits eosinophilic airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Advances in upper airway diseases and allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Characterization of the human cysteinyl leukotriene CysLT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Effects of zafirlukast on bronchial asthma and allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

A mechanism of antigen-induced goblet cell degranulation in the nasal epithelium of sensitized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961317-8

7 January 2021

10.1016/S1081-1206(10)61317-8

Identifiers

DOI

1 reference

12 August 2017

1 reference